EcoDrugPlus

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSACIG00000022845
Gene Symbol: APPB
1 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSACIG00000020156
Gene Symbol: APP
2 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSACIG00000009926
Gene Symbol: AR
1 Cross references
214 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSACIG00000018743
Gene Symbol: AGTR1
1 Cross references
203 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSACIG00000014635
Gene Symbol: AGTR2
1 Cross references
189 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSACIG00000001441
Gene Symbol: APLNR2
1 Cross references
172 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSACIG00000015706
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSACIG00000021356
Gene Symbol: ALOX5A
1 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSACIG00000023670
Gene Symbol: ALOX5AP
1 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSACIG00000017632
Gene Symbol: AVPR1A
1 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSACIG00000018231
Gene Symbol: AVPR1AB
1 Cross references
203 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSACIG00000023316
Gene Symbol: AVPR2
1 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).